• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Viatris Inc (NQ: VTRS )

    11.62 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Viatris Inc

    < Previous 1 2
    ...
    6 7 8 9 10 11 12 13 Next >
    Earnings Scheduled For November 8, 2021
    Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... 
    Via Benzinga
    Unusual Options Activity Insight: Viatris
    On Monday, shares of Viatris (NASDAQ:VTRS) saw unusual opt... 
    Via Benzinga
    The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
    Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
    Via Benzinga
    Exposures Product Safety
    Could Viatris Stock Help You Retire a Millionaire?
    It depends on how much help you're looking for. 
    Via The Motley Fool
    Topics Retirement
    Exposures Pension
    3 No-Brainer Biotech Stocks to Buy Right Now
    Regeneron Pharmaceuticals, Vertex Pharmaceuticals, and Viatris should have plenty of room to run. 
    Via The Motley Fool
    2 Ultra-Cheap Stocks Trading Below Their Book Values
    And these stocks also pay relatively high dividends. 
    Via The Motley Fool
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Viatris Inc. and Encourages Investors who Formerly Held Shares of Mylan Inc. (MYL) to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    Why Are Theravance Bio Shares Plummeting Premarket Today?
    Theravance Biopharma Inc (NASDAQ: TBPH) will reduce its headcount by approximately 75% (estimated 270 positions), with most of the lay off to complete in November... 
    Via Benzinga
    Why Wall Street Thinks This Dirt Cheap Value Stock Could Soar
    It's kind of a boring stock. But analysts think that it could deliver not-so-boring growth. 
    Via The Motley Fool
    Got $5,000? These 2 Dividend Stocks Are Dirt Cheap Buys
    And their yields are both over 3%. 
    Via The Motley Fool
    3 Things About Pfizer That Smart Investors Know
    They're all about the future. 
    Via The Motley Fool
    Theravance Stock Crashes; Can Longer Testing Salvage Its J&J-Partnered Drug?
    Theravance said late Monday its ulcerative colitis treatment failed in midstage testing, and the biotech stock plummeted early Tuesday. 
    Via Investor's Business Daily
    3 Top Biotech Stocks to Buy in August
    Each of these companies makes for a great vehicle to play an aging demographic. 
    Via The Motley Fool
    Analysts Love This Newly Formed Healthcare Company; Should You?
    Viatris' steady operating results and cheap valuation are two key reasons for its high one-year price target. 
    Via The Motley Fool
    Viatris Inc (VTRS) Q2 2021 Earnings Call Transcript
    VTRS earnings call for the period ending June 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    How This Historic FDA Approval Benefits Viatris
    Here's what the FDA's approval of Semglee, from Viatris and Biocon, means for the former. 
    Via The Motley Fool
    Exposures Product Safety
    Viatris Stock Gains After FDA Approves Viatris-Biocon Biologics' Insulin Glargine Biosimilar Injection
    The FDA cleared Viatris inc (NASDAQ: VTRS) - Biocon Biologics' Semglee insulin glargine-yfgn injection as a biosimilar. Semglee indicates controlling high... 
    Via Benzinga
    Exposures Product Safety
    Earnings Scheduled For August 9, 2021
    Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
    Via Benzinga
    The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    Exposures Product Safety
    How To Find Value Stocks July 2021
    Identifying fair value in an inflated stock market is really important, because in all markets, whether bull or bear you can always find value. 
    Via Talk Markets
    10 Worst Performing S&P 500 Stocks Of 2021
    The S&P 500 has continued its late-2020 momentum in the first two quarters of the year, gaining more than 15% year-to-date. Most U.S. investors have had a lot of winners in... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Viatris Stock Rocketed Higher in May
    This undervalued dividend stock finally found its footing in May. 
    Via The Motley Fool
    2 Best Value Stocks to Buy Now
    Looking for solid companies trading on the cheap? Here are your top bets! 
    Via The Motley Fool
    2 Healthcare Stocks That Could Be Millionaire-Makers
    The combination of stability and innovation makes these giants safe bets for long-term returns. 
    Via The Motley Fool
    The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ... 
    Via Benzinga
    Is Viatris a Good Stock to Buy for 2021?
    Long-term investors might want to consider adding this recently formed pharmaceutical company to their portfolios. 
    Via The Motley Fool
    Why Is No One Talking About Viatris Stock?
    This company is one of the largest manufacturers of generic pharmaceuticals in the world, but it may be underpriced. 
    Via The Motley Fool
    Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
    Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an... 
    Via Benzinga
    Not Just GameStop, WallStreetBets' Target Melvin Capital Closed All Public Short Positions In Q1
    Hedge fund Melvin Capital Management LP, which was at the heart of the GameStop Corp. (NYSE: GME) short squeeze frenzy earlier this year, closed out of all its public short... 
    Via Benzinga
    Viatris Inc (VTRS) Q1 2021 Earnings Call Transcript
    VTRS earnings call for the period ending March 31, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    < Previous 1 2
    ...
    6 7 8 9 10 11 12 13 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.